Modulating lipid peroxidation sensitivity through the JAK-STAT1 pathway and the SOCS1-p53 axis may offer new avenues for innovative cancer treatments by emphasizing the significance of immune-mediated lipid peroxidation in tumor suppression. Here, TP53 is linked to neoplasm.